Biosynthetic Melanin Fentanyl Capture via pH-Responsive Binding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for new uses of melanin beyond its current applications in protective coatings, thermal protection, energy storage, bioremediation, and biomedical imaging.

Innovation Solution

Utilizing melanin to reversibly bind fentanyl, allowing for its capture and potential neutralization or detection, through a method involving contact with an aqueous sample containing fentanyl under specific conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If melanin is used to bind fentanyl, then fentanyl capture efficiency is improved, but the ability to release fentanyl for detection or neutralization may be compromised

Engineering Contradiction:
Improvefentanyl capture efficiencyVSAvoidfentanyl release capability
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent applies parameter changes by utilizing pH transitions to control the binding and release of fentanyl by melanin. At neutral pH, melanin binds fentanyl effectively; when acid is added, the pH changes and causes fentanyl to be released from melanin. This reversible parameter change enables both capture and release functions.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent implements dynamics by creating a reversible binding system where melanin can transition between bound and unbound states with fentanyl. The system dynamically adjusts its binding affinity in response to pH changes, allowing it to capture fentanyl when needed and release it for detection or neutralization when required.

Inventive Principle:
Principle #15Dynamics

2Adaptability or versatility

If melanin is used for fentanyl binding, then detection and cleaning capability is improved, but the complexity of the binding mechanism increases

Engineering Contradiction:
Improvedetection and cleaning capabilityVSAvoidbinding mechanism complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent applies self-service by utilizing the intrinsic properties of melanin to bind and release fentanyl without requiring external catalysts or complex mechanisms. The natural pH-responsive behavior of melanin enables it to autonomously capture and release fentanyl, simplifying the overall system while maintaining detection and cleaning capabilities.

Inventive Principle:
Principle #25Self-service

3Quantity of substance

If melanin is used to capture fentanyl, then the concentration of fentanyl in the environment is reduced, but the time required for binding and release cycles increases

Engineering Contradiction:
Improvefentanyl concentration reductionVSAvoidbinding and release cycle time
Core Design Contradiction:
Quantity of substanceVSLoss of time

Solution Approach 1:

The patent utilizes parameter changes through rapid pH transitions to accelerate the binding and release cycles. By adding acid, the system quickly shifts from the bound state to the unbound state, reducing the time required for release while maintaining effective fentanyl capture during the neutral pH phase.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Melanin effectively captures and can release fentanyl, demonstrating a novel method for detecting and cleaning fentanyl from environments, with specific types of melanin showing high binding and de-binding efficiencies.

Implementation Method 1

contacting an aqueous sample containing fentanyl with melanin under conditions allowing the fentanyl to bind to the melanin

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 2

the fentanyl can be de-bound using acid

Methodology Applied
Scientific EffectDe-binding: Desorption

Data Source

PatentUS20250109047A1Capturing fentanyl using biosynthetic melanin
Publication Date: 2025.04.03 THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
  • US20250109047A1 patent drawing
  • US20250109047A1 patent drawing
  • US20250109047A1 patent drawing

AI summary

Biosynthetic melanin can capture fentanyl from aqueous environments. The captured fentanyl can be released by introducing the fentanyl-bound melanin to an acidic environment. In this way, fentanyl can capture melanin for subsequent detection/analysis, in addition to operating to remove fentanyl for decontamination.